Trials / Completed
CompletedNCT03622502
The Effect of Dexmedetomidine for Emergence Cough
The Effect of Dexmedetomidine on the Remifentanil Concentration for Preventing Cough During Emergence After Propofol Anesthesia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Ajou University School of Medicine · Academic / Other
- Sex
- All
- Age
- 19 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Dexmedetomidine or remifentanil are effective in attenuating cough during peri-extubation period after general anesthesia. The purpose of this study was to investigate the effect of dexmedetomidine on the remifentanil concentration for the cough suppression during anesthetic emergence.
Detailed description
Administration of dexmedetomidine before end of surgery could reduce airway reflexes and hemodynamic changes during tracheal extubation. Compared with remifentanil alone, administration of dexmedetomidine in combination with remifentanil is effective in relieving cough and hemodynamic changes without inhibition of respiration. The purpose of this study was to investigate the effect of dexmedetomidine on the remifentanil concentration for the cough suppression during anesthetic emergence using the modified up-and-down method.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexmedetomidine | Dexmedetomidine 0.5mcg/kg was infused over 10 min before end of the surgery |
| DRUG | Remifentanil | Remifentanil was maintained at predetermined effect-site concentration during the periextubation period (initial concentration: 2.0 ng/ml) |
| DRUG | Normal saline | Normal saline was infused over 10 min before end of the surgery |
Timeline
- Start date
- 2018-08-16
- Primary completion
- 2019-03-22
- Completion
- 2019-03-27
- First posted
- 2018-08-09
- Last updated
- 2020-01-09
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03622502. Inclusion in this directory is not an endorsement.